Treatment costs of long-term invasive meningococcal disease sequelae: A literature review and Delphi study in Brazil
Open Access
- 19 February 2025
- journal article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 29 (2) , 104514
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline Biologicals
- GSK
This publication has 26 references indexed in Scilit:
- Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance DatabaseInfectious Diseases and Therapy, 2021
- Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysisInternational Journal of Infectious Diseases, 2019
- Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their CaregiversInfectious Diseases and Therapy, 2018
- Costs of Invasive Meningococcal Disease: A Global Systematic ReviewPharmacoEconomics, 2018
- Direct Costs Associated to Meningococcal Disease and Related Sequelae in Children – Analysis Based on the Brazilian Public Health System PerspectiveValue in Health, 2016
- Lifetime cost of meningococcal disease in France: Scenarios of severe meningitis and septicemia with purpura fulminansJournal of Infection and Public Health, 2016
- Epidemiology and costs of meningococcal disease in brazil: A survey of the literatureValue in Health, 2013
- Counting the Cost of Meningococcal DiseasePediatric Drugs, 2013
- Costs of Sequelae Associated with Invasive Meningococcal Disease: Findings from a US Managed Care PopulationHealth Outcomes Research in Medicine, 2011
- Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998Health Economics, 2003